Hi there!
We track 49,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Gen1E Lifesciences
GEn1E Lifesciences is a clinical-stage, Phase 2 company focused on accelerating first-in-class precision therapies for inflammatory and rare diseases using a unique AI-driven drug development…
Gen1E Lifesciences
GEn1E Lifesciences is a clinical-stage, Phase 2 company focused on accelerating first-in-class precision therapies for inflammatory and rare diseases using a unique AI-driven drug development…
TL;DR
Stage: Clinical-stage (Phase 2 asset)
Lead asset: GEn-1124 (Phase 2 for ARDS)
Platform: Proprietary GRID AI drug discovery platform
Employees: 17
Company Overview
Problem Domain
Inflammatory diseases and rare diseases driven by kinase dysregulation (e.g., ARDS).
Founded
2019
Industry
Biotechnology
Tech Stack
Funding Track Record
Latest disclosed round per company profiles
Investor Signal
“Includes VC and accelerator investors such as Khosla Ventures, Clear Ventures, Leblon Capital, 10X Capital, Y Combinator, and angel/backing groups”